Immunotherapy boosts chemotherapy in combating stage 3 colon cancer
June 01, 2025
June 01, 2025
ROCHESTER, Minnesota, June 1 [Category: BizHospital] -- The Mayo Clinic issued the following news release:
* * *
Immunotherapy boosts chemotherapy in combating stage 3 colon cancer
*
Late-breaking abstract featured at ASCO 2025
ROCHESTER, Minn. -- Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon c . . .
* * *
Immunotherapy boosts chemotherapy in combating stage 3 colon cancer
*
Late-breaking abstract featured at ASCO 2025
ROCHESTER, Minn. -- Colon cancer is the third most prevalent form of cancer in the U.S., and while screening has helped detect and prevent colon cancer from spreading, major advancements in treating colon c . . .